Khoo Teck Kim, Coenen Michael J, Schiefer A Reagan, Kumar Seema, Bahn Rebecca S
Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota 55905, USA.
Thyroid. 2008 Dec;18(12):1291-6. doi: 10.1089/thy.2008.0255.
Thy-1 is a surface protein that defines functionally distinct subpopulations of fibroblasts, with those lacking the antigen being capable of adipogenesis. Because increased fat cell development is a hallmark of the orbit in Graves' ophthalmopathy (GO), we wished to compare baseline Thy-1 expression in orbital fibroblasts from GO patients and normal individuals, and determine whether levels of the protein might be impacted by adipogenesis following peroxisome proliferator activator-gamma ligation.
Orbital adipose/connective tissue specimens were obtained from euthyroid patients undergoing orbital decompression surgery for severe GO (n = 9) and from normal individuals (n = 9). Thy-1 mRNA and protein levels were assessed in tissue specimens and in orbital fibroblast cultures at baseline using RT-PCR, quantitative immunofluorescent staining, and flow cytometry using a specific Thy-1 mouse anti-human CD90/Thy-1 monoclonal antibody. In addition, some orbital fibroblast cultures were treated with rosiglitazone (1 microL/mL; 2 nM) or control for 10 days in culture.
We found that Thy-1 mRNA and protein expression was higher in uncultured GO connective/adipose tissue specimens (3.8-fold; 0.835 +/- 0.116 relative expression) compared with normal (0.22 +/- 0.062; p = 0.002) and in cultured orbital fibroblasts from GO patients (3.3-fold; 9.28 +/- 1.82 relative expression) compared with normal cultures (2.80 +/- 0.42; p = 0.013). Adipocyte differentiation had no effect on Thy-1 expression. Flow cytometry and immunofluorescent staining showed increased numbers of Thy-1-positive cells in the GO (mean 77.9 + 4.09%; range 66.5-84.8%) compared with the normal fibroblast cultures (66.8 + 1.6%; range 63.3-71.0% positive; p = 0.046), as well as higher levels of expression on the positive cells.
Increased Thy-1 expression in GO orbital tissues and cultures is likely a consequence of the orbital disease process, reflecting both the presence of increased numbers of Thy-1-positive cells and higher expression on those cells. Adipogenesis itself does not appear to impact Thy-1 expression. Increased expression of this protein in GO could represent an adaptive response to cell injury, in effect limiting disease progression within the orbital adipose/connective tissues.
Thy-1是一种表面蛋白,可定义功能不同的成纤维细胞亚群,缺乏该抗原的成纤维细胞能够发生脂肪生成。由于脂肪细胞发育增加是格雷夫斯眼病(GO)眼眶病变的一个标志,我们希望比较GO患者和正常个体眼眶成纤维细胞中Thy-1的基线表达,并确定过氧化物酶体增殖物激活剂-γ 连接后脂肪生成是否会影响该蛋白的水平。
从因严重GO接受眼眶减压手术的甲状腺功能正常患者(n = 9)和正常个体(n = 9)获取眼眶脂肪/结缔组织标本。使用RT-PCR、定量免疫荧光染色以及使用特异性Thy-1小鼠抗人CD90/Thy-1单克隆抗体的流式细胞术,在基线时评估组织标本和眼眶成纤维细胞培养物中的Thy-1 mRNA和蛋白水平。此外,一些眼眶成纤维细胞培养物在培养中用罗格列酮(1 μL/mL;2 nM)或对照处理10天。
我们发现,与正常组织(0.22 ± 0.062;p = 0.002)相比,未培养的GO结缔组织/脂肪组织标本中Thy-1 mRNA和蛋白表达更高(3.8倍;相对表达为0.835 ± 0.116),与正常培养物(2.80 ± 0.42;p = 0.013)相比,GO患者培养的眼眶成纤维细胞中Thy-1 mRNA和蛋白表达更高(3.3倍;相对表达为9.28 ± 1.82)。脂肪细胞分化对Thy-1表达没有影响。流式细胞术和免疫荧光染色显示,与正常成纤维细胞培养物(66.8 ± 1.6%;阳性范围63.3 - 71.0%;p = 0.046)相比,GO中Thy-1阳性细胞数量增加(平均77.9 + 4.09%;范围66.5 - 84.8%),并且阳性细胞上的表达水平更高。
GO眼眶组织和培养物中Thy-1表达增加可能是眼眶疾病过程的结果,反映了Thy-1阳性细胞数量增加以及这些细胞上更高的表达。脂肪生成本身似乎不会影响Thy-1表达。GO中该蛋白表达增加可能代表对细胞损伤的适应性反应,实际上限制了眼眶脂肪/结缔组织内的疾病进展。